Detalles de la búsqueda
1.
What is the optimal duration of androgen deprivation therapy in prostate cancer patients presenting with prostate-specific antigen levels > 20 ng/ml?
Can J Urol
; 14(4): 3621-7, 2007 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-17784982
2.
Prospective evaluation of the prevalence and severity of fatigue in patients with prostate cancer undergoing radical external beam radiotherapy and neoadjuvant hormone therapy.
Can J Urol
; 13(3): 3139-46, 2006 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-16813705
3.
Endoscopic response predicts for survival and organ preservation after primary chemoradiotherapy for esophageal cancer.
Int J Radiat Oncol Biol Phys
; 57(5): 1328-35, 2003 Dec 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-14630270
4.
Is there a role for acupuncture in the symptom management of patients receiving palliative care for cancer? A pilot study of 20 patients comparing acupuncture with nurse-led supportive care.
Acupunct Med
; 29(3): 173-9, 2011 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-21666275
5.
Extreme-risk prostate adenocarcinoma presenting with prostate-specific antigen (PSA)>40 ng/ml: prognostic significance of the preradiation PSA nadir.
Int J Radiat Oncol Biol Phys
; 81(5): e713-9, 2011 Dec 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-21277102
6.
Prospective evaluation of a 12-week walking exercise program and its effect on fatigue in prostate cancer patients undergoing radical external beam radiotherapy.
Am J Clin Oncol
; 34(4): 350-5, 2011 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-20686404
7.
Prognostic significance of blood transfusions in patients with esophageal cancer treated with combined chemoradiotherapy.
Am J Clin Oncol
; 30(5): 492-7, 2007 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-17921709
8.
Examining time intervals between diagnosis and treatment in the management of patients with limited stage small cell lung cancer.
Am J Clin Oncol
; 29(1): 21-6, 2006 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-16462498
Resultados
1 -
8
de 8
1
Próxima >
>>